Court Says No to Actavis Plan to Thwart Namenda Generics

A U.S. Court of Appeals has upheld a December decision declaring that Ireland-based Actavis must keep Namenda, it's dementia drug, on the market.
Source: PharmaManufacturing.com - Category: Pharmaceuticals Source Type: news